Treosulfan-based conditioning in 6 pediatric and adolescent patients with non-malignant diseases and haematological malignancies

被引:0
|
作者
Sovinz, P. [1 ]
Schwinger, W. [1 ]
Lackner, H. [1 ]
Benesch, M. [1 ]
Strenger, V. [1 ]
Seidel, M. [1 ]
Urban, C. [1 ]
机构
[1] Med Univ Graz, Graz, Austria
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S384 / S384
页数:1
相关论文
共 50 条
  • [31] SCT with reduced-intensity conditioning in paediatric patients with non-malignant diseases
    Matthes-Martin, S
    Fritsch, G
    Lion, T
    Lawitschka, A
    Attarbashi, A
    Gadner, H
    Karlhuber, S
    Peters, C
    BONE MARROW TRANSPLANTATION, 2005, 35 : S58 - S58
  • [32] Unrelated cord blood transplantation in pediatric patients with non-malignant diseases
    Kurtzberg, J
    Martin, PL
    Carter, SL
    Kernan, NA
    Sabdev, I
    Wall, D
    Pietryga, D
    Wagner, JE
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (11) : 935 - 936
  • [33] IMPACT OF PRETRANSPLANT MRD IN PATIENTS ALLOGRAFTED FOR AML AFTER TREOSULFAN-BASED CONDITIONING
    Pyka, Jacob
    Leimkuehler, Nils
    Schneider, Artur
    Kaivers, Jennifer
    Trenschel, Rudolf
    Mohring, Annemarie
    Reinhardt, Christian
    Schroeder, Thomas
    Rautenberg, Christina
    BONE MARROW TRANSPLANTATION, 2024, 59 : 261 - 262
  • [34] Allogeneic Stem Cell Transplantation in Patients ≥ 65 Years with Hematological Malignancies after Myeloablative treosulfan-based Conditioning: Results in 118 Patients
    Piemontese, Simona
    Lazzari, Lorenzo
    Marcatti, Magda
    Giglio, Fabio
    Greco, Raffaella
    Clerici, Daniela
    Stanghellini, Maria Teresa Lupo
    Assanelli, Andrea
    Farina, Francesca
    Lorentino, Francesca
    Mastaglio, Sara
    Marktel, Sarah
    Carrabba, Matteo
    Corti, Consuelo
    Bernardi, Massimo
    Peccatori, Jacopo
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 291 - 292
  • [35] Successful treosulfan-based conditioning in patients with inborn errors: a single-centre experience
    Comoli, P.
    Poddighe, D.
    Calafiore, L.
    Bergami, E.
    Pozzi, M.
    Visconti, C.
    Rundo, B.
    Guerini, P.
    Ottonello, G.
    Zavras, N.
    Giorgiani, G.
    Bonetti, F.
    Zecca, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S159 - S159
  • [36] Hematopoietic Stem Cell Transplantation with Treosulfan-Based Conditioning in Children of the First Year of Life is Safe and Effective Way of Treatment of Malignant Diseases
    Kirgizov, K.
    Pristanskova, E.
    Burya, A.
    Sidorova, N.
    Blagonravova, O.
    Skorobogatova, E.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S222 - S223
  • [37] Phase II prospective multi-centre study of treosulfan-based conditioning in allogeneic HSCT for haematological malignancies from 10/10 HLA identical unrelated donor
    Michallet, M.
    Sobh, M.
    Morisset, S.
    Bay, J. O.
    Harousseau, J. -L.
    Mohty, M.
    Yakoub-Agha, I.
    Buzyn, A.
    Milpied, N.
    Nicolini, F.
    Labussiere, H.
    Tedone, N.
    Tabrizi, R.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S291 - S291
  • [38] Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases
    O Ringdén
    P Svenberg
    K Le Blanc
    J Mattsson
    M Remberger
    Bone Marrow Transplantation, 2006, 38 : 321 - 322
  • [39] Radioimmunotherapy as part of reduced-intensity conditioning in paediatric patients with non-malignant diseases
    Schulz, AS
    Friedrich, W
    Blumstein, N
    Neininger, M
    Debatin, KM
    Reske, S
    BONE MARROW TRANSPLANTATION, 2006, 37 : S208 - S209
  • [40] Late effects after treosulfan-based conditioning for allogeneic HSCT in children with hematologic malignancies: a single-center experience
    Skvortsova, Yulia
    Shipitsina, Irina
    Balashov, Dmitrij
    Trakhtman, Pavel
    Blagonravova, Oksana
    Persiantseva, Marina
    Skorobogatova, Elena
    Papusha, Lyudmila
    Gutovskaya, Elena
    Shelikhova, Larisa
    Kurnikova, Elena
    Voronin, Kirill
    Maschan, Michail
    Maschan, Alexej
    BONE MARROW TRANSPLANTATION, 2018, 53 : 345 - 346